Brief: Trevi Therapeutics Announces Third Quarter 2022 Financial Results And Provides Business Update
10/11/2022 22:04
Nov 10 (Reuters) - Trevi Therapeutics Inc TRVI.O :
* TREVI THERAPEUTICS ANNOUNCES THIRD QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* TREVI THERAPEUTICS INC QTRLY LOSS PER SHARE $0.12
Source text for Eikon: ID:nPn8FlVDna
Further company coverage: TRVI.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Trevi Therapeutics
See all newsTrevi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Trevi Therapeutics Q2 net loss widens on higher R&D costs
Brief: Trevi Therapeutics Q2 Net Income USD -17.797 Million
Trevi Therapeutics Q1 net loss widens as R&D costs rise
Brief: Trevi Therapeutics Q1 Net Income USD -13.192 Million